USPTO serial 90620233
STRATEOS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Oct 25, 2022
- Examiner
- PATEL, SAMIR RAMESH
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with STRATEOS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Menlo Park, CA
Menlo Park, CA
Menlo Park, CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Stacey J. Watson, Esq.
Stacey J. Watson, Esq. MARKERY LAW LLCP.O. BOX 84150GAITHERSBURG, MD 20883-4150UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Software as a service featuring software which provides access to remote and on- demand automated cloud labs accessible from a web browser that enable users around the world to easily access and control drug discovery, cell and gene therapy and synthetic biology workflows; software as a service featuring software for creating and managing workflows for designing laboratory experiments, for running laboratory experiments, generating data, for reviewing and analyzing laboratory and environmental data, and experiment results; providing scientific and laboratory support services to the pharmaceutical, biotechnology, healthcare, synthetic biology, agricultural science, and medical device industries, namely, research services, biopharmaceutical development, biologic assay development, preclinical research, clinical research, and pharmacovigilance; research and development in the field of biotechnology, healthcare delivery, synthetic biology, biopharmaceuticals, and pharmacovigilance, inclusive of preclinical research in the foregoing fields; software as a service featuring software for enabling organizations to control their own scientific instruments and facilities locally and worldwide, schedule workflows and manage their scientific data; software as a service featuring software for running computer simulations of laboratory experiments, for running computer simulations of biological and chemical phenomena and systems, for optimizing laboratory experiment parameters with computational methods, and for comparison of computer simulations against empirically observed laboratory experiment results; software as a service featuring software for research and development of chemicals, pharmaceuticals, biologics, and vaccines, and cell and gene therapies; software as a service featuring software for providing regulatory compliance documentation following experiments, for performing regulatory agencies audits following experiments, and for performing internal audits following experiments; conducting laboratory experiments on behalf of others; scientific testing services of chemicals, pharmaceuticals, biologics, vaccines, and cell and gene therapies; toxicology services, namely toxicological testing services of pharmaceuticals, chemicals, biologics, vaccines, and cell and gene therapies; research, design and scientific testing services in the field of biopharmaceuticals and synthetic biology; scientific development of custom assays for chemicals, pharmaceuticals, biologics, vaccines, and cell and gene therapies; technological consultancy in the field of information technology; technological consultancy in the field of life sciences, drug discovery, synthetic biology software engineering, hardware engineering and laboratory automation | ACTIVE | Sep 23, 2019 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 25, 2022 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Oct 25, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 9, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 9, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 20, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 6, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 14, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 14, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 14, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 15, 2021 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 15, 2021 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 15, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 17, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 10, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 6, 2021 | NWAP | NEW APPLICATION ENTERED | — |